Gene · 2548
Papers2,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From Acid Alpha-Glucosidase Deficiency to Autophagy: Understanding the Bases of POMPE Disease. | Int J Mol Sci | 2023 | 37569856 | PubTator, text mining | PubMed |
| Integrated Analysis Identifies DPP7 as a Prognostic Biomarker in Colorectal Cancer. | Cancers (Basel) | 2023 | 37568770 | PubTator, text mining | PubMed |
| Bacterial amylases enable glycogen degradation by the vaginal microbiome. | Nat Microbiol | 2023 | 37563289 | PubTator, text mining | PubMed |
Population Pharmacokinetic Modeling and Determination of Individual Exposure to Avalglucosidase Alfa in Adolescent and Adult Patients With Late-Onset Pompe Disease: Analysis of Pooled Data From Phase I to III Clinical Trials. | Ther Drug Monit | 2023 | 37556417 | PubTator, text mining | PubMed |
| Genotype, phenotype and treatment outcomes of 17 Malaysian patients with infantile-onset Pompe disease and the identification of 3 novel GAA variants. | Orphanet J Rare Dis | 2023 | 37542277 | PubTator, text mining | PubMed |
| Hypertrophy cardiomyopathy: A case of infantile-onset Pompe disease in cardiac magnetic resonance findings. | Heliyon | 2023 | 37539106 | PubTator, text mining | PubMed |
| Population pharmacokinetic modeling and dosing simulation of avalglucosidase alfa for selecting alternative dosing regimen in pediatric patients with late-onset pompe disease. | J Pharmacokinet Pharmacodyn | 2023 | 37535240 | PubTator, text mining | PubMed |
| Long-range PCR amplification-based targeted enrichment & next generation sequencing: A cost-effective testing strategy for lysosomal storage disorders. | Indian J Med Res | 2023 | 37530313 | PubTator, text mining | PubMed |
| Limb-Girdle Muscular Dystrophies Classification and Therapies. | J Clin Med | 2023 | 37510884 | PubTator, text mining | PubMed |
| Sea Bass Side Streams Extracts Obtained by Pulsed Electric Fields: Nutritional Characterization and Effect on SH-SY5Y Cells. | Foods | 2023 | 37509809 | PubTator, text mining | PubMed |
| Clinically actionable secondary findings in 130 triads from sub-Saharan African families with non-syndromic orofacial clefts. | Mol Genet Genomic Med | 2023 | 37496383 | PubTator, text mining | PubMed |
| A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC-OXPHOS axis. | J Transl Med | 2023 | 37496051 | PubTator, text mining | PubMed |
| ORC1 binds to cis-transcribed RNAs for efficient activation of replication origins. | Nat Commun | 2023 | 37488096 | PubTator, text mining | PubMed |
| Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix. | Genome Biol | 2023 | 37480112 | PubTator, text mining | PubMed |
| Glycogen storage diseases: An update. | World J Gastroenterol | 2023 | 37476587 | PubTator, text mining | PubMed |
| Preserving mitochondria to treat hypertrophic cardiomyopathy: From rare mitochondrial DNA mutation to heart failure therapy? | J Clin Invest | 2023 | 37463442 | PubTator, text mining | PubMed |
| AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice. | JCI Insight | 2023 | 37463048 | PubTator, text mining | PubMed |
| Cardiac magnetic resonance of hypertrophic heart phenotype: A review. | Heliyon | 2023 | 37441401 | PubTator, text mining | PubMed |
| A new compact adenine base editor generated through deletion of HNH and REC2 domain of SpCas9. | BMC Biol | 2023 | 37434184 | PubTator, text mining | PubMed |
| One-year longitudinal study of the stratum corneum proteome of retinol and all-trans-retinoic acid treated human skin: an orchestrated molecular event. | Sci Rep | 2023 | 37433822 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2548/papers?page=15